HHS Finalizes Health Plan Price Transparency Rule
C&M Health Law
NOVEMBER 23, 2020
The Departments’ estimates for the immediate regulatory compliance costs of the rule wildly outstrip the estimates for the rule’s potential savings. Insurer stakeholders, on the other hand, caution that disclosing privately negotiated rates will reduce incentives to offer lower rates, resulting in higher costs in some markets.
40 
Let's personalize your content